Therapeutic Agent Toxicity Recruiting Phase 2 Trials for Rivoceranib (DB14765)

Also known as: Drug Toxicity / Toxicity, Drug / Toxicity / Drug intoxication / Drug poisoning / Poisoning by unspecified drug or medicinal substance / Drug toxicity NOS / Drug toxicity (NOS) / Poisoning by drug AND/OR medicinal substance (disorder) / Poisoning (disorder) / Toxic effect of unspecified substance, accidental (unintentional) / Poisoning / Poisoning NOS / Toxicity to various agents

IndicationStatusPhase
DBCOND0083667 (Therapeutic Agent Toxicity)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04351308Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade OsteosarcomaTreatment
NCT06281886Induction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Locally Advanced Esophageal Squamous Cell CarcinomaTreatment